Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rejuvenon
AddedFeb 17, 2024
UpdatedJun 18, 2026
Rejuvenon

Rejuvenon

Closed

Rejuvenon: A dedicated biopharmaceutical firm specializing in oncologic treatment development.

HQ
Houston, TX, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Rejuvenon, a biopharmaceutical company, was founded with the mission to develop and commercialize innovative compounds for the treatment of oncologic diseases. The company's core vision is to advance cancer treatment and improve patient outcomes through cutting-edge research and development. Rejuvenon focuses on creating therapeutic solutions that address unmet medical needs in oncology, aiming to bring new hope to patients and healthcare providers.

Notable figures associated with Rejuvenon include leading scientists and industry experts in oncology and pharmaceuticals. The company has attracted significant investment from venture capital firms specializing in biotech innovations. Key achievements include the successful development of promising compounds that have shown efficacy in preclinical trials. Rejuvenon's impact lies in its potential to revolutionize cancer treatment, offering new avenues for therapy and contributing to the broader fight against cancer.

Rejuvenon - Similar Companies

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Cullinan Oncology logo

Cullinan Oncology

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

Zenopharm logo

Zenopharm

Juvenescence logo

Juvenescence

juvlabs.com

Visiox logo

Visiox

visioxpharma.com

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

UroGen Pharma logo

UroGen Pharma

urogen.com

Oncolix logo

Oncolix

Curelab Oncology logo

Curelab Oncology

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Traws Pharma logo

Traws Pharma

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Regennova logo

Regennova

regennova.com

Rejuvenon - Quick Facts

Who are Rejuvenon's competitors?

Companies similar to Rejuvenon include Rejuveron Life Sciences, Cullinan Oncology, Rejuvenate Bio and Zenopharm.

When was Rejuvenon founded?

Rejuvenon was founded in 2000.

Where is Rejuvenon's headquarters located?

Rejuvenon's headquarters is located in Houston, TX, US.

When was Rejuvenon's last funding round?

Rejuvenon's most recent funding round was for $37M (USD) in June 2004.

How much has Rejuvenon raised to-date?

As of Jun 23, 2004, Rejuvenon has raised a total of $49M (USD).

Rejuvenon - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology
  • Therapeutics
Tags
  • Financial
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified